| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
1 Oral and Pharyngeal Cancer Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland; and 2 Laser Skin and Surgery Center of New York, New York, New York
Ras genes are the most frequently mutated oncogenes in human cancer. However, the contribution of ras to tumor initiation still is unclear because ras expression in primary cells can cause cell cycle arrest and even cell death by apoptosis. Furthermore, when expressed in the epidermis of mice, mutant ras promotes the formation of benign papillomas, only few of which will progress into carcinomas. However, in these cases, ras-transgene expression often is restricted to suprabasal or follicular epithelial cells that may lack self-renewal capacity. Thus, it still is conceivable that expression of active ras in other epithelial compartments may exert a distinct ability to promote malignant progression. To address this possibility, transgenic mice carrying the tetracycline-inducible system (tet-on receptor) targeted to the basal layer of stratified epithelium, which includes the epithelial stem cells, were engineered and crossed with mice expressing the K-rasG12D oncogene under the control of tet-regulated responsive elements. On doxycycline administration, proliferative lesions ranging from hyperplasias, papillomas, and dysplasias to metastatic carcinomas developed in squamous epithelia of the skin, oral mucosa, salivary glands, tongue, esophagus, forestomach, and uterine cervix within just 10 to 20 days. The most noticeable lesions were invasive squamous carcinomas of the skin and oral mucosa. These findings suggest that the expression of oncogenes in an epithelial compartment that includes the stem cells may be sufficient to promote squamous carcinogenesis. They also provide a molecularly defined conditional animal model system in which the mechanisms responsible for cancer initiation, maintenance, and metastatic spread can be readily investigated.
This article has been cited by other articles:
![]() |
P. Arun, M. S. Brown, R. Ehsanian, Z. Chen, and C. Van Waes Nuclear NF-{kappa}B p65 Phosphorylation at Serine 276 by Protein Kinase A Contributes to the Malignant Phenotype of Head and Neck Cancer Clin. Cancer Res., October 1, 2009; 15(19): 5974 - 5984. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Raimondi, A. Molinolo, and J. S. Gutkind Rapamycin Prevents Early Onset of Tumorigenesis in an Oral-Specific K-ras and p53 Two-Hit Carcinogenesis Model Cancer Res., May 15, 2009; 69(10): 4159 - 4166. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vitale-Cross, R. Czerninski, P. Amornphimoltham, V. Patel, A. A. Molinolo, and J. S. Gutkind Chemical Carcinogenesis Models for Evaluating Molecular-Targeted Prevention and Treatment of Oral Cancer Cancer Prevention Research, May 1, 2009; 2(5): 419 - 422. [Full Text] [PDF] |
||||
![]() |
A. Klinakis, M. Szabolcs, G. Chen, S. Xuan, H. Hibshoosh, and A. Efstratiadis Igf1r as a therapeutic target in a mouse model of basal-like breast cancer PNAS, February 17, 2009; 106(7): 2359 - 2364. [Abstract] [Full Text] [PDF] |
||||
![]() |
N E Lueck and R A Robinson High levels of expression of cytokeratin 5 are strongly correlated with poor survival in higher grades of mucoepidermoid carcinoma J. Clin. Pathol., July 1, 2008; 61(7): 837 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-J. Oh, V. Rishi, S. Pelech, and C. Vinson Histological and proteomic analysis of reversible H-RasV12G expression in transgenic mouse skin Carcinogenesis, October 1, 2007; 28(10): 2244 - 2252. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Arena, C. Isella, M. Martini, A. de Marco, E. Medico, and A. Bardelli Knock-in of Oncogenic Kras Does Not Transform Mouse Somatic Cells But Triggers a Transcriptional Response that Classifies Human Cancers Cancer Res., September 15, 2007; 67(18): 8468 - 8476. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hameyer, A. Loonstra, L. Eshkind, S. Schmitt, C. Antunes, A. Groen, E. Bindels, J. Jonkers, P. Krimpenfort, R. Meuwissen, et al. Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues Physiol Genomics, September 11, 2007; 31(1): 32 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, M. M Fergusson, R. M. Castilho, J. Liu, L. Cao, J. Chen, D. Malide, I. I. Rovira, D. Schimel, C. J. Kuo, et al. Augmented Wnt Signaling in a Mammalian Model of Accelerated Aging Science, August 10, 2007; 317(5839): 803 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Funes, M. Quintero, S. Henderson, D. Martinez, U. Qureshi, C. Westwood, M. O. Clements, D. Bourboulia, R. B. Pedley, S. Moncada, et al. Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production PNAS, April 10, 2007; 104(15): 6223 - 6228. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K.S. Ku, D. C. Nguyen, M. Karaman, P. Gill, J. G. Hacia, and D. L. Crowe Loss of p53 Expression Correlates with Metastatic Phenotype and Transcriptional Profile in a New Mouse Model of Head and Neck Cancer Mol. Cancer Res., April 1, 2007; 5(4): 351 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Teng, A.-N. Sun, X.-C. Pan, G. Yang, L.-L. Yang, M.-R. Wang, and X. Yang Synergistic Function of Smad4 and PTEN in Suppressing Forestomach Squamous Cell Carcinoma in the Mouse. Cancer Res., July 15, 2006; 66(14): 6972 - 6981. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Lu, H. Herrington, D. Reh, S. Weber, S. Bornstein, D. Wang, A. G. Li, C.-F. Tang, Y. Siddiqui, J. Nord, et al. Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes & Dev., May 15, 2006; 20(10): 1331 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Raimondi, L. Vitale-Cross, P. Amornphimoltham, J. S. Gutkind, and A. Molinolo Rapid Development of Salivary Gland Carcinomas upon Conditional Expression of K-ras Driven by the Cytokeratin 5 Promoter Am. J. Pathol., May 1, 2006; 168(5): 1654 - 1665. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |